How to cure the incurable with cell and gene therapy

Explore the latest developments and future horizons in cell and gene therapy with fellow experts in the field

Sponsored by

Overcome common hurdles in scaling up mRNA-based therapeutics

“At GeneLeap, we focus on utilizing mRNA for vaccine development, drug discovery, and lipid nanoparticle delivery technology platforms. Our vision is to redefine the possibilities in healthcare by looking beyond traditional therapies. We develop synthetic, modified mRNA drugs with the capability to encode a wide range of natural and engineered proteins designed to be absorbed by specific cells in designated tissues or organs. This mechanism focuses on diseases where targeted cell activation can significantly aid the body in combating or preventing various health conditions.” - Xinyue (Frank) Zhang, Manager of mRNA Process Development at GeneLeap Biotechnolog

Read article

Non-viral transposon versus lentiviral delivery

Learn about how a novel non-viral gene delivery system that could transform cell and gene therapy workflows.

Read article

mRNA manufacturing to boost therapy and vaccine output

mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to a new manufacturing unit at the University of Sheffield.

Visit resource

Targeted mass spectrometry for quantitative protein analysis

Daniel Liebler, Vice President of Proteomic Technology at Inotiv, shares a patented mass-spectrometry-based platform for quantitative protein analysis.

Read article

ddPCR to innovate replication-competent virus testing

Dipika Gurnani shares how ddPCR™ technology could transform RCV testing in gene therapy workflows.

Read article

Optimize AAV capsid purification using mass photometry

Find out how viral vector experts accelerate their AAV capsid purification using mass photometry.

Download resource

AAV aggregate quantitation and identification

Learn how you can explore AAV stability and subvisible aggregates using as low as 10 μL per sample.

Download resource

Empowering advancement across cell and gene therapy

Advancements in the field of human genomics, transcriptomics, and proteomics have given rise to high-throughput, affordable, and potentially life-changing cell and gene therapies to treat individuals with genetic diseases. Explore our feature to gain expert insights into:

How gene editing heralds new therapeutic era

Breakthrough therapies to transform healthcare

Novel gene delivery for targeted therapeutics

Who are the innovators of personalized medicine?

Accelerating Science Forum: Longevity and compliance in cell and gene therapies

Join our panel of multidisciplinary experts as they consider the longevity and compliance of cell and gene therapies.

As part of this Accelerating Science Feature, SelectScience® will bring together experts and industry leaders in cell and gene therapy research, manufacturing, and compliance to discuss the first-ever approval of a gene-editing-based therapy Casgevy.

Exploring the potential of other innovative cell and gene therapy types alongside this critical approval, key topics such as monitoring long-term efficacy, identifying potential risks, improving manufacturing processes, optimizing dosing regimens, and developing robust monitoring systems, will also be discussed.

Whether you are a researcher, healthcare professional, industry representative, or simply interested in the future of medicine, this event will equip you with valuable knowledge and understanding of the challenges and potential solutions related to the longevity and compliance of cell and gene therapies.

Watch on demand here

Share your story, scientific knowledge, and accelerate science by becoming a SelectScience member.

Join for free today

A special thank you to all our sponsors of this feature. If you'd like to be involved, please contact us.

*Certain images and/or photos on this page are the copyrighted property of 123RF.com or Adobe Stock, its contributors or its licensed partners and are being used with permission under the relevant license. These images and/or photos may not be copied or downloaded without permission from 123RF.com or Adobe Stock.